Novel compounds with promising IDO1 inhibitory activity as new cancer drug candidates: Derivatives of N,N'-diphenylurea linked with 1,2,3-triazole

文献类型: 外文期刊

第一作者: Sun, Bin

作者: Sun, Bin;Liu, Xiaofei;Sun, Xiuwei;Mao, Longfei;Shi, Weichen;Deng, Peng;Liu, Xiaofei;Sun, Xiuwei;Zhou, Yingjie;Mao, Longfei;Gong, Xiaoqing;Shi, Weichen;Shi, Lin;Shi, Lin

作者机构: Shandong NormColl Chem Chem Engn & Mat Sci, Collaborat Innovat Ctr Functionalized Probes Chem, Shandong Prov Key Lab Clean Prod Fine Chemicalsal, Key Lab Mol & Nano Probes,Minist Educ, Jinan, Peoples R China;Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agroprod Proc Technol Shandong Prov, Key Lab Novel Food Resources Proc,Minist Agr, Jinan 250100, Peoples R China;Jinan Asia Pharm Tech Co Ltd, Jinan, Peoples R China;Henan Normal Univ, Sch Chem & Chem Engn, Xinxiang, Peoples R China;Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou, Peoples R China;Shandong First Med Univ, Dept Thyroid Surg, Affiliated Hosp 1, Jinan, Peoples R China;Shandong First Med Univ, Dept Ultrasound Diag, Shandong Prov Hosp, Jinan, Peoples R China;Shandong First Med Univ, Shandong Prov Hosp, Treatment Dept, Jinan 250021, Peoples R China

期刊名称:PHARMAZIE ( 2022影响因子:1.6; 五年影响因子:1.6 )

ISSN: 0031-7144

年卷期: 2023 年 78 卷 1-4 期

页码:

收录情况: SCI

摘要: To explore potential indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors, we designed a series of compounds incorporating urea and 1,2,3-triazole structures. IDO1 enzymatic activity experiments with the synthesized compounds were used to verify their molecular-level activity; for instance, the half maximal inhibitory concentra-tion value of compound 3c was 0.07 mu M. Our research has yielded a series of novel IDO1 inhibitors which may be beneficial in the development of drugs targeting IDO1 for cancer treatment.

分类号:

  • 相关文献
作者其他论文 更多>>